Christopher W. Mastropietro

Christopher W. Mastropietro

Auto-generated profile, based on publicly available information

Christopher W. Mastropietro

Division of Critical Care, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Ind

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
SAS. Abu-Sultaneh
S. Abu-Sultaneh
NINarayan Prabhu Iyer
Narayan Prabhu Iyer
AFAnalía Fernández
Analía Fernández
MGMichael Gaies
Michael Gaies
SGSebastián González-Dambrauskas
Sebastián González-Dambrauskas
RKRobinder G. Khemani
Robinder G. Khemani
Rationale: Pediatric-specific ventilator liberation guidelines are lacking despite the many studies exploring elements of extubation readiness testing. The lack of clinical practice guidelines has led to significant and unnecessary variation in methods used to assess pediatric patients’ readiness for extubation. Methods: Twenty-six international experts comprised a multiprofessional panel to establish pediatrics-specific ventilator liberation clinical practice guidelines, focusing on acutely hospitalized children receiving invasive mechanical ventilation for more than 24 hours. Eleven key questions were identified and first prioritized using the Modified Convergence of Opinion on Recommendations and Evidence. A systematic review was conducted for questions that did not meet an a priori threshold of ⩾80% agreement, with Grading of Recommendations, Assessment, Development, and Evaluation methodologies applied to develop the guidelines. The panel evaluated the evidence and drafted and voted on the recommendations. Measurements and Main Results: Three questions related to systematic screening using an extubation readiness testing bundle and a spontaneous breathing trial as part of the bundle met Modified Convergence of Opinion on Recommendations criteria of ⩾80% agreement. For the remaining eight questions, five systematic reviews yielded 12 recommendations related to the methods and duration of spontaneous breathing trials, measures of respiratory muscle strength, assessment of risk of postextubation upper airway obstruction and its prevention, use of postextubation noninvasive respiratory support, and sedation. Most recommendations were conditional and based on low to very low certainty of evidence. Conclusions: This clinical practice guideline provides a conceptual framework with evidence-based recommendations for best practices related to pediatric ventilator liberation.

4 October 2016 in Pediatric Research
Verified
Journal Article
Open access
MYMouhammad Yabrodi
Mouhammad Yabrodi
CMChristopher W. Mastropietro
Christopher W. Mastropietro
The management of hypoplastic left heart syndrome (HLHS) has changed substantially over the past four decades. In the 1970s, children with HLHS could only be provided with supportive care. As a result, most of these unfortunate children died within the neonatal period. The advent of the Norwood procedure in the early 1980s has changed the prognosis for these children, and the majority now undergoing a series of three surgical stages that can support survival beyond the neonatal period and into early adulthood. This review will focus on the Norwood procedure and the other important innovations of the last half century that have improved our outlook toward children born with HLHS.

20 February 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JWJill J Williams
Jill J Williams
KMKorapat Mayurasakorn
Korapat Mayurasakorn
SVSusan J Vannucci
Susan J Vannucci
CMChristopher Mastropietro
Christopher Mastropietro
NBNicolas G Bazan
Nicolas G Bazan
Richard J. DeckelbaumRichard J. Deckelbaum
Richard J. Deckelbaum
We questioned if acute administration of n-3 fatty acids (FA) carried in n-3 rich triglyceride (TG) emulsions provides neuroprotection in neonatal mice subjected to hypoxic-ischemic (H/I) brain injury. We examined specificity of FA, optimal doses, and therapeutic windows for neuroprotection after H/I. H/I insult was induced in C57BL/6J 10-day-old mice by right carotid artery ligation followed by exposure to 8% O2 for 15 minutes at 37°C. Intraperitoneal injection with n-3-rich TG emulsions, n-6 rich TG emulsions or saline for control was administered at different time points before and/or after H/I. In separate experiments, dose responses were determined with TG containing only docosahexaenoic acid (Tri-DHA) or eicosapentaenoic acid (Tri-EPA) with a range of 0.1–0.375 g n-3 TG/kg, administered immediately after H/I insult. Infarct volume and cerebral blood flow (CBF) were measured. Treatment with n-3 TG emulsions both before- and after- H/I significantly reduced total infarct volume by a mean of 43% when administered 90 min prior to H/I and by 47% when administered immediately after H/I. In post-H/I experiments Tri-DHA, but not Tri-EPA exhibited neuroprotective effects with both low and high doses (p<0.05). Moreover, delayed post-H/I treatment with Tri-DHA significantly decreased total infarct volume by a mean of 51% when administered at 0 hr, by 46% at 1 hr, and by 51% at 2 hr after H/I insult. No protective effect occurred with Tri-DHA injection at 4 hr after H/I. There were no n-3 TG related differences in CBF. A significant reduction in brain tissue death was maintained after Tri-DHA injection at 8 wk after the initial brain injury. Thus, n-3 TG, specifically containing DHA, is protective against H/I induced brain infarction when administered up to 2 hr after H/I injury. Acute administration of TG-rich DHA may prove effective for treatment of stroke in humans.

1 June 2019 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
CMChristopher W. Mastropietro
Christopher W. Mastropietro
VAVenu Amula
Venu Amula
PSPeter Sassalos
Peter Sassalos
JBJason R. Buckley
Jason R. Buckley
ASArthur J. Smerling
Arthur J. Smerling
JCJohn M. Costello
John M. Costello

1 March 2017 in The Journal of Pediatrics
Verified
Journal Article
Closed access
CMChristopher W. Mastropietro
Christopher W. Mastropietro
KCKatherine Cashen
Katherine Cashen
LGLisa M. Grimaldi
Lisa M. Grimaldi
KGKeshava Murty Narayana Gowda
Keshava Murty Narayana Gowda
KPKurt D. Piggott
Kurt D. Piggott
JCJohn M. Costello
John M. Costello

1 November 2015 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
NLNina Laudato
Nina Laudato
PGPooja Gupta
Pooja Gupta
HWHenry L. Walters
Henry L. Walters
RDRalph E. Delius
Ralph E. Delius
CMChristopher W. Mastropietro
Christopher W. Mastropietro
Extubation failure after neonatal cardiac surgery has been associated with considerable postoperative morbidity, although data identifying risk factors for its occurrence are sparse. We aimed to determine risk factors for extubation failure in our neonatal cardiac surgical population. Retrospective chart review. Urban tertiary care free-standing children's hospital. Neonates (0-30 d) who underwent cardiac surgery at our institution between January 2009 and December 2012 was performed. Extubation failure was defined as reintubation within 72 hours after extubation from mechanical ventilation. Multivariate logistic regression analysis was performed to determine independent risk factors for extubation failure. We included 120 neonates, of whom 21 (17.5%) experienced extubation failure. On univariate analysis, patients who failed extubation were more likely to have genetic abnormalities (24% vs 6%; p = 0.023), hypoplastic left heart (43% vs 17%; p = 0.009), delayed sternal closure (38% vs 12%; p = 0.004), postoperative infection prior to extubation (38% vs 11%; p = 0.002), and longer duration of mechanical ventilation (median, 142 vs 58 hr; p = 0.009]. On multivariate analysis, genetic abnormalities, hypoplastic left heart, and postoperative infection remained independently associated with extubation failure. Furthermore, patients with infection who failed extubation tended to receive fewer days of antibiotics prior to their first extubation attempt when compared with patients with infection who did not fail extubation (4.9 ± 2.6 vs 7.3 ± 3; p = 0.073). Neonates with underlying genetic abnormalities, hypoplastic left heart, or postoperative infection were at increased risk for extubation failure. A more conservative approach in these patients, including longer pre-extubation duration of antibiotic therapy for postoperative infections, may be warranted.